A double-blind, placebo-controlled, phase-II clinical trial to evaluate oral simvastatin as a treatment for vitiligo-Reference-Cited by-同舟云学术

A double-blind, placebo-controlled, phase-II clinical trial to evaluate oral simvastatin as a treatment for vitiligo

Published:2017-01 Issue:1 Volume:76 Page:150-151.e3
ISSN:0190-9622
Container-title:Journal of the American Academy of Dermatology
language:en
Short-container-title:Journal of the American Academy of Dermatology

Author:

Vanderweil Stefan G.,Amano Shinya,Ko Wei-Che,Richmond Jillian M.,Kelley Michelle,Senna Maryanne Makredes,Pearson Andrea,Chowdary Sandhya,Hartigan Celia,Barton Bruce,Harris John E.

Publisher

Elsevier BV

Subject

Dermatology

Reference5 articles.

1. CXCL10 is critical for the progression and maintenance of depigmentation in a mouse model of vitiligo;Rashighi;Sci Transl Med,2014

2. Statins downregulate K6a promoter activity: a possible therapeutic avenue for pachyonychia congenita;Zhao;J Invest Dermatol,2011

3. Simvastatin prevents and reverses depigmentation in a mouse model of vitiligo;Agarwal;J Invest Dermatol,2015

4. Positive pleiotropic effects of HMG-CoA reductase inhibitor on vitiligo;Noël;Lipids Health Dis,2004

5. Vitiligo Area Scoring Index and Vitiligo European Task Force assessment: reliable and responsive instruments to measure the degree of depigmentation in vitiligo;Komen;Br J Dermatol,2015

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vitiligo: From Pathogenesis to Treatment;Journal of Clinical Medicine;2024-09-03

2. A comparative study of narrow-band ultraviolet B alone versus with low dose simvastatin in the treatment of vitiligo: impact on chemokine C-X-C motif ligand 10 and chemokine C–C motif ligand 8;Journal of the Egyptian Women's Dermatologic Society;2024-08-30

3. PCSK9 Inhibitors and the Risk of Vitiligo: A Mendelian Randomization Study;Journal of Investigative Dermatology;2024-08

4. Topical application of simvastatin acid sodium salt and atorvastatin calcium salt in vitiligo patients. Results of the randomized, double-blind EVRAAS pilot study;Scientific Reports;2024-06-25

5. Research Progress in Small Molecules as Anti-vitiligo Agents;Current Medicinal Chemistry;2024-03